Treating Bugs with Bugs: The Role of Probiotics as Adjunctive Therapy for Helicobacter pylori
- 21 June 2011
- journal article
- research article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 45 (7-8) , 960-966
Abstract
Objective: To review the literature on the role of probiotics as adjunctive therapy in the treatment of Helicobacter pylori infections. Data Sources: Literature was accessed through MEDLINE (1966-March 2011) using the terms H. pylori, probiotic, Lactobacillus, Bifidobacterium, Saccharomyces, Bacillus clausii, and Propionibacterium. Article references were hand-searched for additional relevant articles and abstracts. Study Selection and Data Extraction: All English-language articles published in full were evaluated. Randomized, double-blind, placebo-controlled trials assessing the use of probiotics combined with standard eradication therapy of H. pylori infection in adults were included in the review. Data Synthesis: Various probiotics, including Lactobacillus spp., Saccharomyces spp., Bifidobacterium spp., and B. clausii, reduce adverse effects such as nausea, taste disturbance, diarrhea, and epigastric pain, and increase tolerability of H. pylori eradication therapy. Based on the studies reviewed, probiotics do not affect H. pylori eradication rates. Conclusions: Probiotics may be beneficial in reducing adverse effects and increasing tolerability of H. pylori eradication regimens. They may especially be helpful in patients with recurrent H. pylori infection and a history of gastrointestinal adverse effects with antibiotics. Pharmacists can play an important role in educating patients regarding probiotic use during H. pylori eradication therapy.Keywords
This publication has 25 references indexed in Scilit:
- Systematic Review of the Symptom Burden, Quality of Life Impairment and Costs Associated with Peptic Ulcer DiseaseThe American Journal of Medicine, 2010
- Role of Lactobacillus in the Prevention of Antibiotic‐Associated Diarrhea: A Meta‐analysisPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2010
- Dietary and socio-economic factors in relation to Helicobacter pylori re-infectionWorld Journal of Gastroenterology, 2009
- American College of Gastroenterology Guideline on the Management of Helicobacter pylori InfectionAmerican Journal of Gastroenterology, 2007
- Meta‐analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapyAlimentary Pharmacology & Therapeutics, 2006
- Helicobacter and Digestive MalignanciesHelicobacter, 2006
- Meta-Analysis of Probiotics for the Prevention of Antibiotic Associated Diarrhea and the Treatment of Clostridium difficile DiseaseAmerican Journal of Gastroenterology, 2006
- Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori?Alimentary Pharmacology & Therapeutics, 2006
- Meta‐analysis: the effect of probiotic administration on antibiotic‐associated diarrhoeaAlimentary Pharmacology & Therapeutics, 2002
- Cure of duodenal ulcer associated with eradication of Helicobacter pyloriThe Lancet, 1990